Concepedia

Thomas H. Lanthorn

TH

Statistics

Publications

55

Citations

3.5K

H-Index

31

Active since

1978

Affiliations

Lexicon Pharmaceuticals (United States)(Current)

University of Florida

Monsanto (United States)

University of California, Irvine

Institute for Biological Sciences

Thomas H. Lanthorn is an author at Lexicon Pharmaceuticals (United States) specializing in neuroscience, neuropharmacology, and pharmacology.

Publications per year

1978–2016

55

Publications

55

Kynurenic acid inhibits synaptic and acidic amino acid-induced responses in the rat hippocampus and spinal cord

Alan H. Ganong, Thomas H. Lanthorn, Carl W. Cotman · Brain Research · 1983 · 304 citations

, , +11

Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants

Katerina V. Savelieva, Shulei Zhao, Vladimir M. Pogorelov et al. · PLoS ONE · 2008 · 256 citations · Full text

, , +17

An overview of glutamate as a neurotransmitter.

Cotman Cw, Alan C. Foster, Thomas H. Lanthorn · PubMed · 1981 · 185 citations

, , +10

d-Cycloserine acts as a partial agonist at the glycine modulatory site of the NMDA receptor expressed inXenopus oocytes

Gerald B. Watson, M A Bolanowski, Mark P. Baganoff et al. · Brain Research · 1990 · 172 citations

, , +13

The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist

John E. Macor, David Gurley, Thomas H. Lanthorn et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 159 citations · Full text

, , +15

1–5 of 55